Clinical Trial Update: 5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial evaluating epigenetic therapy with azacitidine and decitabine for myeloid malignancies; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Myeloproliferative Neoplasms Crossover Syndromes
• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Decitabine (Decitabine)

Snippet

Sponsor: Benjamin Tomlinson | Conditions: Myelodysplastic Syndromes, MDS/MPN Crossover Syndromes | EARLY_Phase 1 | Status: RECRUITING